Pelthos Therapeutics Inc. ( PTHS) - Key Metrics
PTHS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.41 | -$6.62 | -$2.17 | -$2.17 |
| 2026Q1 | $3.29 | -$3.09 | -$3.96 | -$4.02 |
| 2025Q4 | $2.98 | -$6.87 | -$1.98 | -$2.01 |
| 2025Q3 | $11.56 | -$25.35 | -$23.82 | -$23.82 |
| 2025Q2 | $0 | -$5.38 | -$0.70 | -$0.70 |
PTHS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.07 |
| 2026Q1 | 0% | -1.70 |
| 2025Q4 | 0% | -1.13 |
| 2025Q3 | 0% | -0.28 |
| 2025Q2 | 0% | -0.59 |
PTHS
Price: $20.15
52 week price:
Earnings Per Share: -28.63 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 73.0 million